Is Unicycive Therapeutics Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Unicycive Therapeutics Inc (UNCY) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Unicycive Therapeutics Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Unicycive Therapeutics Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Unicycive Therapeutics Inc?

Muslim investors may consider investing in Unicycive Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Unicycive Therapeutics Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Unicycive Therapeutics Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Unicycive Therapeutics Inc updated?

The Shariah compliance status of Unicycive Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Unicycive Therapeutics Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Unicycive Therapeutics Inc?

You can check the latest Shariah compliance status of Unicycive Therapeutics Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

UNCY Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 07, 2026

Report Source: 2025 Annual Report

Unicycive Therapeutics Inc. Stock Analysis UNCY

United States Health Care Micro Cap Report: 2025 Annual

Unicycive Therapeutics, Inc. is a biotechnology company, which engages in developing novel treatments for kidney diseases. The company is headquartered in Los Altos, California and currently employs 21 full-time employees. The company went IPO on 2021-06-17. The firm's lead drug candidate, oxylanthanum carbonate (OLC), is an investigational phosphate binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. Its second asset, UNI-494, is a patent-protected new chemical entity in clinical development for the treatment of conditions related to acute kidney injury.

Key Statistics of Unicycive Therapeutics Inc (UNCY)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$8.12$8.59

Today's Open

$8.50

Volume

828.70K

P/E Ratio (TTM)

52 Week Range

$3.71$11.00

Market Cap

203.92M

Avg. Volume

541.61K

Dividend Yield

Financial Metrics & Statements of Unicycive Therapeutics Inc (UNCY)

FAQ's for Unicycive Therapeutics Inc (UNCY)

According to Musaffa’s Shariah screening methodology, Unicycive Therapeutics Inc (UNCY) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.